Tumor microenvironment regulation - enhanced radio - immunotherapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Research

Background:

• Radiotherapy (RT) shows immune stimulation potential but faces limitations in inhibiting tumor growth and metastasis due to the complex tumor microenvironment (TME).
• Effective strategies are needed to overcome TME-related limitations in RT and immunotherapy combinations.

Purpose of the Study:

• To develop TME-regulating SiO2@MnO2 nanoparticles (SM NPs) for combination therapy with RT and immunotherapy.
• To evaluate the efficacy of SM NPs in enhancing RT's anti-tumor and anti-metastasis effects.

Main Methods:

• Preparation of TME-regulating SM NPs.
• Utilizing a bilateral animal model to assess the effects of SM NPs combined with RT.
• Analyzing TME modulation by measuring oxygen and reactive oxygen species levels.
• Evaluating immune response by quantifying cytokine secretion from macrophage-like cells.

Main Results:

• SM NPs enhanced RT's inhibition of primary tumor growth.
• SM NPs significantly boosted the abscopal effect, inhibiting distant untreated tumors (40% complete inhibition, 40% suppressed growth).
• SM NPs modulated TME by increasing oxygen and reactive oxygen species and enhanced immune responses via cytokine secretion.

Conclusions:

• SM NPs are effective in enhancing radio-immunotherapy by modulating the TME and immune responses.
• This strategy shows potential for simultaneously inhibiting tumor growth and metastasis.
• SM NPs offer a promising approach for overcoming RT resistance and improving cancer treatment outcomes.